“Down Staging of Cirrhosis in All Cirrhotic Patients With HCV Genotype 3-a Infection, Treated With 12-Weeks Triple Therapy, Including Sofosbuvir, Daclatasvir and Ribavirin”. Medical Forum Monthly, vol. 29, no. 3, May 2024, https://medicalforummonthly.com/index.php/mfm/article/view/2891.